Obalon Therapeutics, Inc. OBLN

$ 3.05 -5.86%

Obalon Therapeutics, Inc. EV/EBITDA Ratio 2011-2024 | OBLN

Annual EV/EBITDA Ratio Obalon Therapeutics, Inc.

2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-4.23	0.253	-0.58	-1.83	1.07	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
1.07	-4.23	-1.06